Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system
出版年份 2010 全文链接
标题
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 65, Issue 12, Pages 2556-2565
出版商
Oxford University Press (OUP)
发表日期
2010-09-19
DOI
10.1093/jac/dkq345
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei
- (2010) Zhi-Dong Jiang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Understanding Why Probiotic Therapies Can be Effective in Treating IBD
- (2010) Richard N. Fedorak JOURNAL OF CLINICAL GASTROENTEROLOGY
- Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles
- (2009) E. L. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Different Fecal Microbiotas and Volatile Organic Compounds in Treated and Untreated Children with Celiac Disease
- (2009) R. Di Cagno et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Non-Digestible Food Ingredients, Colonic Microbiota and the Impact on Gut Health and Immunity: A Role for Metabolomics
- (2009) Doris Jacobs et al. CURRENT DRUG METABOLISM
- Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases
- (2009) Christopher D Packey et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The Role of Gut Microbiota in Drug Response
- (2009) I. Wilson et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H Nuclear Magnetic Resonance spectroscopy
- (2009) Maurice Ndagijimana et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Panorganismal Gut Microbiome−Host Metabolic Crosstalk
- (2009) Francois-Pierre J. Martin et al. JOURNAL OF PROTEOME RESEARCH
- Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model
- (2008) K. Saxton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora
- (2008) S. M. Finegold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis
- (2008) Beatrice Vitali et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genome-scale analyses of health-promoting bacteria: probiogenomics
- (2008) Marco Ventura et al. NATURE REVIEWS MICROBIOLOGY
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of central immunity in uncomplicated diverticular disease
- (2008) Rossella Cianci et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Active Crohnʼs disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora
- (2007) Alexander Swidsinski et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search